Atlas Trials

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years

Clinical trial NCT06225115 · COMPLETED

Trial details

NCT number
NCT06225115
Sponsor
Kynexis B.V.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cognitive DysfunctionSchizophrenia
Start date
2023-12-21
Primary completion
2024-10-07
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.